Developer docs
API playgroundTry for free, no card

Search company profiles

Aural Analytics

Full company profile

uuid0000vbw

Namestring
Aural Analytics
Legal namestring
Aural Analytics, Inc.
Company typeenum
Private
Founded yearint
2015
Descriptiontext

Aural Analytics is a clinical-grade speech analytics company spun out of Arizona State University in 2015 and headquartered in Scottsdale, Arizona. The company develops Speech Vitals, a cloud-based platform that combines speech signal processing with cognitive-linguistic analysis to extract objective neuro-biomarkers from speech samples collected via mobile devices. The technology analyzes multiple dimensions of speech production — including respiratory support, phonation quality, articulation rate, oral-nasal resonance, and language complexity — to produce clinically interpretable metrics validated across 15 disease conditions spanning ALS, Parkinson's, Alzheimer's, concussion, autism, depression, and migraine. The Speech Vitals–ALS module received FDA Breakthrough Device Designation in March 2023, and the broader platform was registered with the FDA as a Class II Software as a Medical Device (Computerized Cognitive Assessment Aid) in October 2022.

The product portfolio consists of the Speech Vitals Collection App (iOS/Android), the Speech Vitals-ALS module, and the A2E SDK, which enables embedding of speech endpoints into third-party iOS, Android, and web applications in up to 30 languages. Aural Analytics serves three primary customer segments: pharmaceutical and life sciences companies using Speech Vitals as a digital biomarker endpoint in clinical trials; healthcare systems and neurology practices for cognitive assessment and disease monitoring; and sports medicine organizations for sideline concussion assessment (notably via the HitCheck integration). Distribution is primarily B2B enterprise SaaS subscriptions and SDK licensing, with quote-based multi-year contracts to pharma sponsors, CROs, healthcare systems, and digital biomarker platforms including Medidata's Sensor Cloud Network and Koneksa.

The company is ISO 9001:2015 and ISO 13485:2016 certified, HIPAA and GDPR compliant, and has executed notable engagements including the HEALEY ALS Platform trial with Prilenia Therapeutics (where speech biomarkers first suggested therapeutic efficacy), a Phase III cognitive impairment program with Boehringer Ingelheim, and ALS early-detection work with EverythingALS. In March 2024, Aural Analytics was acquired by Linus Health Inc., a digital cognitive assessment platform, to integrate advanced speech analytics into Linus's broader brain-health offering.

Short descriptiontext

Aural Analytics develops Speech Vitals, a clinical-grade speech analytics platform that extracts objective neuro-biomarkers from speech for neurological disease monitoring, serving pharmaceutical clinical trials, healthcare systems, and sports medicine applications in up to 30 languages.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersScottsdale, United States
HQ citystring
Scottsdale
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical speech analytics, digital biomarkers, neurological disease monitoring, speech-based cognitive assessment, concussion screening software
Industry3 codes
PRIMARYHLACAAAI
Speech Recognition, Dictation & Medical Transcription Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Electronic Health Records (EHR/EMR) & Clinical Documentation
SECONDARYHDAAAFAH
Audio & Speech Analytics (call analytics, QA, insights)
SECONDARYHDAAAJAF
On-Device Speech & Audio AI (wake word, ASR, enhancement)
NAICS code2 codes
  • Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services518210
  • Information51
SIC code2 codes
  • Services-Health Services8000
  • Services-Commercial Physical & Biological Research8731
Product category
Clinical Speech Analytics Software
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Speech Vitals SaaS Platform
TypeSubscription Recurring
Description

Cloud-based subscription licensing of the Speech Vitals platform for clinical trials, remote patient monitoring, and healthcare system deployment. The platform is SDK-ready and embeddable into provider applications for seamless clinical integration.

auralanalytics.com
2A2E SDK Licensing
TypeLicensing Royalties
Description

License fees for embedding the A2E (Aural Analytics Embed) Software Development Kit into third-party clinical research, pharmaceutical, telemedicine, and academic platforms. Supports standard, hybrid and decentralized pharmaceutical clinical trials, remote monitoring and telemedicine deployments.

auralanalytics.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Pricing details1 tier
1Enterprise SaaS licensing for pharmaceutical companies, healthcare systems, and research institutions
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Quote-based / Not publicly disclosed. Licenses are negotiated with pharma sponsors, healthcare providers, and clinical research organizations.

auralanalytics.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 3 records shown
1Speech Vitals
Description

Clinical-grade speech analytics platform that collects speech samples via app-based tasks measuring speaking rate, articulatory precision, phonatory duration and other metrics. FDA-registered as a Computerized Cognitive Assessment Aid.

auralanalytics.com
+2 more records
Core offering1 text field

Aural Analytics builds Speech Vitals, a cloud-based clinical-grade speech analytics platform that combines speech signal processing and cognitive-linguistic analysis into APIs to extract neuro-biomarker measures (respiratory support, phonation quality, articulation rate, oral-nasal resonance, language complexity) from speech samples. The platform exposes these capabilities via the Speech Vitals mobile app and the A2E SDK for embedding into third-party iOS, Android, and web applications, serving pharmaceutical clinical trials, neurology practices, and concussion assessment use cases.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Slowing of decline in speech production attributes (sustained phonation, speaking rate, articulation rate, articulatory precision) in ALS patients taking Pridopidine vs. placebo, as demonstrated in the HEALEY ALS Platform trial Regimen D
+2 more records
Product overview1 text field

Aural Analytics offers Speech Vitals, a unified cloud-based clinical-grade speech analytics platform. The product portfolio consists of Speech Vitals (core platform) for extracting validated speech biomarkers, Speech Vitals - ALS (specialized variant with FDA Breakthrough Device Designation for ALS monitoring), and the A2E SDK for embedding speech analytics into third-party applications. The Speech Vitals Collection App serves as the patient-facing mobile interface. Together these products enable remote, frequent speech assessments for neurological and respiratory health monitoring across clinical trials and healthcare settings, available in up to 30 languages.

Product and service4 records
1Speech Vitals
CategoryClinical Speech Analytics Platform
Description

Cloud-based clinical-grade speech analytics platform combining speech signal processing and cognitive-linguistic analysis into APIs to extract clinically interpretable neuro-biomarker measures (respiratory support, phonation quality, articulation rate, oral-nasal resonance, language complexity) from speech samples collected via mobile app-based tasks, for use in clinical trials, neurology practices, and remote patient monitoring.

2Speech Vitals - ALS
CategoryClinical Speech Analytics Platform - ALS
Description

ALS-specific speech analytics software collecting speaking rate, articulatory precision, phonatory duration, and other speech-motor metrics via app-based tasks to assist neurologists in monitoring ALS progression in adults in clinic and at home.

3A2E (Aural Analytics Embed) SDK
CategorySpeech Analytics SDK / API
Description

Software Development Kit that lets clinical researchers, pharmaceutical sponsors, telemedicine providers, and CROs embed Speech Vitals speech analytics endpoints into iOS, Android, and web applications with minimal code, supporting standard, hybrid, and decentralized clinical trials and remote monitoring.

4Speech Vitals Collection App
CategoryMobile Speech Collection App
Description

Mobile application for collecting speech samples from patients via structured elicitation tasks, capturing speaking rate, articulatory precision, word search time, and other validated metrics; available on iOS and Android and SDK-ready for embedding into provider and healthcare system applications.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership11 partners
Strategic tierCoreTypeOthersAnnounced on2024-03-01
Description

Linus Health acquired Aural Analytics in March 2024 to strengthen its digital cognitive assessment platform with advanced speech analytics for early detection of cognitive impairments. Linus Health presented clinical validation studies at AD/PD conferences and has partnerships with pharmaceutical and life sciences companies supporting clinical trials for Alzheimer's, Parkinson's, ALS, and mental health conditions.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-02-24
Description

Aural Analytics' Speech Vitals platform was used in the HEALEY ALS Platform trial (Regimen D) evaluating Pridopidine, where the speech-motor module demonstrated that participants taking Pridopidine showed slowing of decline in speech production attributes (sustained phonation, speaking rate, articulation rate, articulatory precision). This was the first time a speech-based digital biomarker suggested therapeutic efficacy in a large-scale pre-registered interventional trial.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2022-10-18
Description

Aural Analytics embedded its clinical-grade speech analytics into HitCheck's cognitive assessment app to enhance sideline concussion protocol decision-making. The partnership adds a sub-2-minute speech assessment to HitCheck's interactive, game-like concussion screening, comparing post-injury results against athletes' personal baseline assessments. HitCheck serves 200,000+ users across four countries with partnerships including the NFL Alumni Association and Baylor Scott & White Health.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-09-20
Description

Aural Analytics was selected for EverythingALS' 12-month early detection study for ALS using Speech Vitals technology. The study aims to demonstrate efficacy of speech analysis in early ALS detection using data from speech analytics, sole-based sensors, and hand-held spirometer integrated with demographics and clinical data, with the goal of developing a novel Digital ALSFRS-R scale.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2022-07-21
Description

Aural Analytics' Speech Vitals integrated as a standard offering within Medidata's Sensor Cloud Network, enabling pharmaceutical researchers to leverage speech analytics at scale across clinical trials. This collaboration deploys Speech Vitals to further the breadth of data streams for researchers to characterize treatment effect, phenotype participants, and gain real-world disease understanding.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-06-14
Description

Partnership to integrate speech collection into Koneksa's clinical trials and digital biomarker development programs with a focus on neurodegenerative conditions. The goal is to make it easy to add speech measures to Koneksa studies across pharma development and commercial pipelines, with both companies' research-grade platforms optimized for clinical trials at scale.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-08-05
Description

Aural Analytics, SARRC, and Arizona State University partnered on an interventional clinical research study targeting cognition, social communication and mood in adults with autism spectrum disorder. Aural Analytics sponsors speech and language biomarker collection via its Speech Vitals platform, integrated into a behavioral intervention study (Strengthening Skills program combining PEERS and cognitive compensation training) for 48 autistic adults aged 21-70 over two years.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-08-05
Description

Partnership with ASU's College of Health Solutions alongside SARRC on autism spectrum disorder research. ASU and SARRC had previously conducted research showing reduced executive functioning and elevated depression/anxiety in middle-age autistic adults. Aural Analytics' speech biomarkers will measure cognitive and social communication outcomes in the study.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2021-01-01
Description

Partnership in the NIH Cancer Moonshot Project, integrating speech analytics into Medable's decentralized clinical research platform to support the initiative's goals of improving patient access and engagement in cancer research.

10Boehringer Ingelheim
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-01-01
Description

Partnership with Boehringer Ingelheim on an innovative Phase III program for a breakthrough therapy in cognitive impairment associated with schizophrenia, using Aural Analytics' Speech Vitals speech analytics platform.

auralanalytics.com
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2021-01-01
Description

Aural Analytics participated in the Bio-Hermes Clinical Trial, which launched to compare biomarker tests and seek rapid, less expensive diagnostics for Alzheimer's Disease, contributing speech analytics as a digital biomarker modality.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Parent company of Aural Analytics and a digital cognitive assessment platform targeting early detection of cognitive impairment. Operates in the same neurological assessment category with overlapping pharma and clinical research customers, and acquired Aural Analytics in March 2024 to incorporate speech-based digital biomarkers.

TypeDirect peer
Description

Speech analytics company developing vocal biomarkers for cognitive impairment and CNS clinical trials. Closely comparable to Aural Analytics in applying speech-based digital endpoints to neurodegenerative and psychiatric drug development.

TypeDirect peer
Description

Vocal biomarker company using short voice samples to detect and monitor health conditions including mental and cognitive health. Targets similar enterprise customers (health plans, pharma, digital health) with speech-based health monitoring.

TypeDirect peer
Description

AI-driven speech and video assessment platform for neurological and psychiatric conditions. Provides remote, automated clinical assessments using speech and facial analysis, directly competing in digital biomarker space for clinical trials and tele-neurology.

TypeDirect peer
Description

Digital biomarker company integrating wearables and remote assessments into clinical trials for pharma and academic research. Partner of Aural Analytics (Speech Vitals integrated into Koneksa platform) and a peer in digital biomarker deployment for CNS trials.

TypeBroad incumbent
Description

Clinical trial technology platform with Sensor Cloud Network integrating Aural Analytics' Speech Vitals. A large incumbent offering speech analytics as a standard offering within its broader clinical research suite.

TypeDirect peer
Description

Provider of cognitive assessment tools and digital biomarkers for CNS clinical trials, including speech-based and computerized tests. Serves pharma, biotech, and academic researchers with validated cognitive endpoints, comparable to Speech Vitals.

TypeDirect peer
Description

Computerized cognitive assessment provider for clinical trials, healthcare, and concussion management. A peer in digital cognitive testing with FDA-cleared tools, overlapping in CNS clinical trial endpoints and concussion screening markets.

TypeEmerging player
Description

Cognitive assessment mobile application for concussion screening used by sports organizations. Partner that embeds Aural Analytics' speech analytics for its sub-2-minute speech assessment component.

TypeBroad incumbent
Description

Clinical trial technology and imaging provider offering decentralized trial solutions and digital biomarkers, including for CNS indications. Competes with Aural Analytics as a broad incumbent in trial endpoint technology.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors6 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Aural Analytics

Clinical Speech Analytics Softwareauralanalytics.com

Aural Analytics develops Speech Vitals, a clinical-grade speech analytics platform that extracts objective neuro-biomarkers from speech for neurological disease monitoring, serving pharmaceutical clinical trials, healthcare systems, and sports medicine applications in up to 30 languages.

What Aural Analytics does

Aural Analytics is a clinical-grade speech analytics company spun out of Arizona State University in 2015 and headquartered in Scottsdale, Arizona. The company develops Speech Vitals, a cloud-based platform that combines speech signal processing with cognitive-linguistic analysis to extract objective neuro-biomarkers from speech samples collected via mobile devices. The technology analyzes multiple dimensions of speech production — including respiratory support, phonation quality, articulation rate, oral-nasal resonance, and language complexity — to produce clinically interpretable metrics validated across 15 disease conditions spanning ALS, Parkinson's, Alzheimer's, concussion, autism, depression, and migraine. The Speech Vitals–ALS module received FDA Breakthrough Device Designation in March 2023, and the broader platform was registered with the FDA as a Class II Software as a Medical Device (Computerized Cognitive Assessment Aid) in October 2022.

The product portfolio consists of the Speech Vitals Collection App (iOS/Android), the Speech Vitals-ALS module, and the A2E SDK, which enables embedding of speech endpoints into third-party iOS, Android, and web applications in up to 30 languages. Aural Analytics serves three primary customer segments: pharmaceutical and life sciences companies using Speech Vitals as a digital biomarker endpoint in clinical trials; healthcare systems and neurology practices for cognitive assessment and disease monitoring; and sports medicine organizations for sideline concussion assessment (notably via the HitCheck integration). Distribution is primarily B2B enterprise SaaS subscriptions and SDK licensing, with quote-based multi-year contracts to pharma sponsors, CROs, healthcare systems, and digital biomarker platforms including Medidata's Sensor Cloud Network and Koneksa.

The company is ISO 9001:2015 and ISO 13485:2016 certified, HIPAA and GDPR compliant, and has executed notable engagements including the HEALEY ALS Platform trial with Prilenia Therapeutics (where speech biomarkers first suggested therapeutic efficacy), a Phase III cognitive impairment program with Boehringer Ingelheim, and ALS early-detection work with EverythingALS. In March 2024, Aural Analytics was acquired by Linus Health Inc., a digital cognitive assessment platform, to integrate advanced speech analytics into Linus's broader brain-health offering.

Aural Analytics firmographics

Firmographics
Name
Aural Analytics
Legal name
Aural Analytics, Inc.
Website
https://auralanalytics.com
Company type
Private
Founded year
2015
Operating status
Acquired
Headcount range
1–10 employees
Short description
Aural Analytics develops Speech Vitals, a clinical-grade speech analytics platform that extracts objective neuro-biomarkers from speech for neurological disease monitoring, serving pharmaceutical clinical trials, healthcare systems, and sports medicine applications in up to 30 languages.
Ownership category
akta.pro rank

Aural Analytics industry classification

Industry
Product category
Clinical Speech Analytics Software
NAICS
Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518210), Information (51)
SIC
Services-Health Services (8000), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLACAAAI
Speech Recognition, Dictation & Medical Transcription Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Electronic Health Records (EHR/EMR) & Clinical Documentation
SECONDARYHDAAAFAH
Audio & Speech Analytics (call analytics, QA, insights)
SECONDARYHDAAAJAF
On-Device Speech & Audio AI (wake word, ASR, enhancement)

Keywords

  • Clinical speech analytics
  • Digital biomarkers
  • Neurological disease monitoring
  • Speech-based cognitive assessment
  • Concussion screening software

Where Aural Analytics is headquartered

Location

Headquarters

HQ city
Scottsdale
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Aural Analytics business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Speech Vitals SaaS Platform: Cloud-based subscription licensing of the Speech Vitals platform for clinical trials, remote patient monitoring, and healthcare system deployment. The platform is SDK-ready and embeddable into provider applications for seamless clinical integration.
  2. A2E SDK Licensing: License fees for embedding the A2E (Aural Analytics Embed) Software Development Kit into third-party clinical research, pharmaceutical, telemedicine, and academic platforms. Supports standard, hybrid and decentralized pharmaceutical clinical trials, remote monitoring and telemedicine deployments.

Pricing tiers

ModelBillingPrice
SubscriptionMulti-year contractEnterprise SaaS licensing for pharmaceutical companies, healthcare systems, and research institutions

Go-to-market motion1 record

Distribution channels5 records

Marketing channels6 records

Aural Analytics product offering

Product offering

Core offering

Aural Analytics builds Speech Vitals, a cloud-based clinical-grade speech analytics platform that combines speech signal processing and cognitive-linguistic analysis into APIs to extract neuro-biomarker measures (respiratory support, phonation quality, articulation rate, oral-nasal resonance, language complexity) from speech samples. The platform exposes these capabilities via the Speech Vitals mobile app and the A2E SDK for embedding into third-party iOS, Android, and web applications, serving pharmaceutical clinical trials, neurology practices, and concussion assessment use cases.

Product overview

Aural Analytics offers Speech Vitals, a unified cloud-based clinical-grade speech analytics platform. The product portfolio consists of Speech Vitals (core platform) for extracting validated speech biomarkers, Speech Vitals - ALS (specialized variant with FDA Breakthrough Device Designation for ALS monitoring), and the A2E SDK for embedding speech analytics into third-party applications. The Speech Vitals Collection App serves as the patient-facing mobile interface. Together these products enable remote, frequent speech assessments for neurological and respiratory health monitoring across clinical trials and healthcare settings, available in up to 30 languages.

Differentiator

Problem solved

Functional benefit

Brands

  • Speech Vitals: Clinical-grade speech analytics platform that collects speech samples via app-based tasks measuring speaking rate, articulatory precision, phonatory duration and other metrics. FDA-registered as a Computerized Cognitive Assessment Aid.
  • A2E (Aural Analytics Embed)
  • Speech Vitals - ALS

Products and services

  • Speech Vitals Cloud-based clinical-grade speech analytics platform combining speech signal processing and cognitive-linguistic analysis into APIs to extract clinically interpretable neuro-biomarker measures (respiratory support, phonation quality, articulation rate, oral-nasal resonance, language complexity) from speech samples collected via mobile app-based tasks, for use in clinical trials, neurology practices, and remote patient monitoring.
  • Speech Vitals - ALS ALS-specific speech analytics software collecting speaking rate, articulatory precision, phonatory duration, and other speech-motor metrics via app-based tasks to assist neurologists in monitoring ALS progression in adults in clinic and at home.
  • A2E (Aural Analytics Embed) SDK Software Development Kit that lets clinical researchers, pharmaceutical sponsors, telemedicine providers, and CROs embed Speech Vitals speech analytics endpoints into iOS, Android, and web applications with minimal code, supporting standard, hybrid, and decentralized clinical trials and remote monitoring.
  • Speech Vitals Collection App Mobile application for collecting speech samples from patients via structured elicitation tasks, capturing speaking rate, articulatory precision, word search time, and other validated metrics; available on iOS and Android and SDK-ready for embedding into provider and healthcare system applications.

Quantifiable outcome

  • Slowing of decline in speech production attributes (sustained phonation, speaking rate, articulation rate, articulatory precision) in ALS patients taking Pridopidine vs. placebo, as demonstrated in the HEALEY ALS Platform trial Regimen D
  • +2 more outcomes

Companies that use Aural Analytics

Customer profile

Named customers5 records

Segments4 records

Ideal customer profiles4 records

Aural Analytics technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability2 records

Feature5 records

Aural Analytics partnerships and signals

Strategic signal

Partnerships

Eleven partnerships are on record, tiered core and minor.

  • Linus HealthcoreOthers · 1 March 2024Linus Health acquired Aural Analytics in March 2024 to strengthen its digital cognitive assessment platform with advanced speech analytics for early detection of cognitive impairments. Linus Health presented clinical validation studies at AD/PD conferences and has partnerships with pharmaceutical and life sciences companies supporting clinical trials for Alzheimer's, Parkinson's, ALS, and mental health conditions.
  • Prilenia TherapeuticscoreStrategic or Co-development Partner · 24 February 2023Aural Analytics' Speech Vitals platform was used in the HEALEY ALS Platform trial (Regimen D) evaluating Pridopidine, where the speech-motor module demonstrated that participants taking Pridopidine showed slowing of decline in speech production attributes (sustained phonation, speaking rate, articulation rate, articulatory precision). This was the first time a speech-based digital biomarker suggested therapeutic efficacy in a large-scale pre-registered interventional trial.
  • HitCheckcoreTechnology or Integration · 18 October 2022Aural Analytics embedded its clinical-grade speech analytics into HitCheck's cognitive assessment app to enhance sideline concussion protocol decision-making. The partnership adds a sub-2-minute speech assessment to HitCheck's interactive, game-like concussion screening, comparing post-injury results against athletes' personal baseline assessments. HitCheck serves 200,000+ users across four countries with partnerships including the NFL Alumni Association and Baylor Scott & White Health.
  • EverythingALScoreStrategic or Co-development Partner · 20 September 2022Aural Analytics was selected for EverythingALS' 12-month early detection study for ALS using Speech Vitals technology. The study aims to demonstrate efficacy of speech analysis in early ALS detection using data from speech analytics, sole-based sensors, and hand-held spirometer integrated with demographics and clinical data, with the goal of developing a novel Digital ALSFRS-R scale.
  • MedidatacoreTechnology or Integration · 21 July 2022Aural Analytics' Speech Vitals integrated as a standard offering within Medidata's Sensor Cloud Network, enabling pharmaceutical researchers to leverage speech analytics at scale across clinical trials. This collaboration deploys Speech Vitals to further the breadth of data streams for researchers to characterize treatment effect, phenotype participants, and gain real-world disease understanding.
  • KoneksacoreStrategic or Co-development Partner · 14 June 2022Partnership to integrate speech collection into Koneksa's clinical trials and digital biomarker development programs with a focus on neurodegenerative conditions. The goal is to make it easy to add speech measures to Koneksa studies across pharma development and commercial pipelines, with both companies' research-grade platforms optimized for clinical trials at scale.
  • Southwest Autism Research & Resource Center (SARRC)coreStrategic or Co-development Partner · 5 August 2021Aural Analytics, SARRC, and Arizona State University partnered on an interventional clinical research study targeting cognition, social communication and mood in adults with autism spectrum disorder. Aural Analytics sponsors speech and language biomarker collection via its Speech Vitals platform, integrated into a behavioral intervention study (Strengthening Skills program combining PEERS and cognitive compensation training) for 48 autistic adults aged 21-70 over two years.
  • Arizona State UniversitycoreStrategic or Co-development Partner · 5 August 2021Partnership with ASU's College of Health Solutions alongside SARRC on autism spectrum disorder research. ASU and SARRC had previously conducted research showing reduced executive functioning and elevated depression/anxiety in middle-age autistic adults. Aural Analytics' speech biomarkers will measure cognitive and social communication outcomes in the study.
  • MedableminorStrategic or Co-development Partner · 1 January 2021Partnership in the NIH Cancer Moonshot Project, integrating speech analytics into Medable's decentralized clinical research platform to support the initiative's goals of improving patient access and engagement in cancer research.
  • Boehringer IngelheimcoreStrategic or Co-development Partner · 1 January 2021Partnership with Boehringer Ingelheim on an innovative Phase III program for a breakthrough therapy in cognitive impairment associated with schizophrenia, using Aural Analytics' Speech Vitals speech analytics platform.
  • Bio-HermesminorStrategic or Co-development Partner · 1 January 2021Aural Analytics participated in the Bio-Hermes Clinical Trial, which launched to compare biomarker tests and seek rapid, less expensive diagnostics for Alzheimer's Disease, contributing speech analytics as a digital biomarker modality.

Scale indicators9 records

Recent moves7 records

Expansion highlights6 records

Aural Analytics competitors and assessment

Company assessment

Broad incumbents

  • Linus Health: Parent company of Aural Analytics and a digital cognitive assessment platform targeting early detection of cognitive impairment. Operates in the same neurological assessment category with overlapping pharma and clinical research customers, and acquired Aural Analytics in March 2024 to incorporate speech-based digital biomarkers.
  • Medidata (Dassault Systèmes): Clinical trial technology platform with Sensor Cloud Network integrating Aural Analytics' Speech Vitals. A large incumbent offering speech analytics as a standard offering within its broader clinical research suite.
  • Bioclinica (Clario): Clinical trial technology and imaging provider offering decentralized trial solutions and digital biomarkers, including for CNS indications. Competes with Aural Analytics as a broad incumbent in trial endpoint technology.

Direct peers

  • Winterlight Labs: Speech analytics company developing vocal biomarkers for cognitive impairment and CNS clinical trials. Closely comparable to Aural Analytics in applying speech-based digital endpoints to neurodegenerative and psychiatric drug development.
  • Sonde Health: Vocal biomarker company using short voice samples to detect and monitor health conditions including mental and cognitive health. Targets similar enterprise customers (health plans, pharma, digital health) with speech-based health monitoring.
  • Modality.ai: AI-driven speech and video assessment platform for neurological and psychiatric conditions. Provides remote, automated clinical assessments using speech and facial analysis, directly competing in digital biomarker space for clinical trials and tele-neurology.
  • Koneksa: Digital biomarker company integrating wearables and remote assessments into clinical trials for pharma and academic research. Partner of Aural Analytics (Speech Vitals integrated into Koneksa platform) and a peer in digital biomarker deployment for CNS trials.
  • Cambridge Cognition: Provider of cognitive assessment tools and digital biomarkers for CNS clinical trials, including speech-based and computerized tests. Serves pharma, biotech, and academic researchers with validated cognitive endpoints, comparable to Speech Vitals.
  • Cogstate: Computerized cognitive assessment provider for clinical trials, healthcare, and concussion management. A peer in digital cognitive testing with FDA-cleared tools, overlapping in CNS clinical trial endpoints and concussion screening markets.

Emerging players

  • HitCheck: Cognitive assessment mobile application for concussion screening used by sports organizations. Partner that embeds Aural Analytics' speech analytics for its sub-2-minute speech assessment component.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Aural Analytics social profiles

Digital presence

Aural Analytics compliance and trust

Trust signal

Compliance5 records

Aural Analytics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Aural Analytics leadership team

Management profile

Number of profiles

Profiles3 records

Aural Analytics funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Aural Analytics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aural Analytics

What does Aural Analytics do?

Aural Analytics builds Speech Vitals, a cloud-based clinical-grade speech analytics platform that combines speech signal processing and cognitive-linguistic analysis into APIs to extract neuro-biomarker measures (respiratory support, phonation quality, articulation rate, oral-nasal resonance, language complexity) from speech samples. The platform exposes these capabilities via the Speech Vitals mobile app and the A2E SDK for embedding into third-party iOS, Android, and web applications, serving pharmaceutical clinical trials, neurology practices, and concussion assessment use cases.

Is Aural Analytics a public or private company?

Aural Analytics is a private company. It is classified as corporate owned and is currently acquired.

When was Aural Analytics founded?

Aural Analytics was founded in 2015. It employs 1 to 10 people.

Where is Aural Analytics based?

Aural Analytics is headquartered in Scottsdale, United States, in the North America region.

How does Aural Analytics make money?

Two revenue lines are on record. Speech Vitals SaaS Platform is the primary driver. The others are A2E SDK Licensing.

Who are Aural Analytics's main competitors?

Broad incumbents on record are Linus Health, Medidata (Dassault Systèmes) and Bioclinica (Clario). Direct peers are Winterlight Labs, Sonde Health, Modality.ai, Koneksa, Cambridge Cognition and Cogstate. HitCheck is listed as an emerging player.

Does Aural Analytics have an API?

Yes. A2E (Aural Analytics Embed) is a Software Development Kit (SDK) that enables clinical researchers and partners to embed speech endpoints into any application (iOS, Android, and web), available in 14+ languages, compliant with HIPAA and GDPR. The SDK provides speech elicitation and analytics that can be integrated with only a few lines of code, targeting pharmaceutical clinical trials, remote monitoring, and telemedicine use cases. The platform supports structured speech tasks and returns validated metrics including speaking rate, articulatory precision, phonatory duration, and other disease-relevant measures.

What industry is Aural Analytics in?

Aural Analytics's product category is Clinical Speech Analytics Software. Its primary akta.pro industry code is HLACAAAI, Speech Recognition, Dictation & Medical Transcription Platforms, with a secondary code of HDAAAFAH, Audio & Speech Analytics (call analytics, QA, insights). Its NAICS code is 518210 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
openPR.comIn-Depth Examination of Segments, Industry Trends, and Key Competitors in the Cognitive Assessment and Training MarketThe cognitive assessment and training market is projected to reach $21.98 billion by 2030, growing at a compound annual growth rate of 23.4%, driven by AI-powered assessment tools, remote learning adoption, and virtual reality-based cognitive solutions. In March 2024, US-based Linus Health Inc. acquired Aural Analytics to strengthen its digital cognitive assessment platform with advanced speech analytics for early detection of cognitive impairments. In July 2024, THREAD, Inc. partnered with Cogstate Limited to combine digital assessment capabilities with decentralized research platforms for central nervous system disorders.openPR.comKey Factors and Emerging Trends Shaping the Brain Health Devices Market LandscapeThe brain health devices market is projected to grow to $16.84 billion by 2030 with a 7.1% CAGR, driven by advances in wearable technology, AI integration, and telehealth adoption. In March 2024, Linus Health Inc. acquired Aural Analytics Inc. to enhance its cognitive assessment platform with speech analytics capabilities for detecting cognitive impairments. In May 2025, Netherlands-based Neurocast launched its FDA-registered smartphone-based monitoring platform in the U.S. to detect neurological changes in patients with conditions like multiple sclerosis, Alzheimer's disease, ADHD, and depression.StartupSeekerAural Analytics - Funding: $1M+Aural Analytics, a Scottsdale-based startup founded in 2015, has raised $1.4 million in funding to develop a speech analytics platform using non-invasive neuro-biomarker technology for remote brain health assessments. The cloud-based software provides healthcare professionals with objective metrics to detect neurological issues early by analyzing speech signals. Major investors include the National Institutes of Health.VatorNewsCognitive assessment platform Linus Health buys speech analytics startup Aural AnalyticsLinus Health has acquired speech analytics startup Aural Analytics to integrate its clinical-grade speech technology into its digital health platform for early dementia detection. This acquisition expands Linus Health's operations into the life sciences industry, allowing it to leverage Aural’s data and tools for pharmaceutical trials and improve cognitive assessment accuracy. The deal adds three new tools to Linus's suite, including a hearing screener and a digital trail making test, aimed at accelerating the identification of mild cognitive impairment.VatorNewsCognitive assessment platform Linus Health buys speech analytics startup Aural AnalyticsLinus Health acquired speech analytics startup Aural Analytics, adding clinical-grade speech analytics to its cognitive assessment platform. The deal, with undisclosed financial terms, incorporates Aural's Speech Vitals technology to expand into life sciences and clinical trials. Linus also launched a Hearing Screener and Digital Trail Making Test.HIT ConsultantLinus Health Acquires Aural Analytics to Enhance Dementia DetectionLinus Health acquired Aural Analytics, a clinical-grade speech analysis platform, to enhance its dementia detection tools. The acquisition integrates Speech Vitals into Linus Health's platform, aiming for earlier and more accurate diagnoses. It also enables Linus Health to offer its technology to pharmaceutical companies for drug development and clinical trials.MorningstarLinus Health Acquires Aural AnalyticsLinus Health acquired Aural Analytics, a clinical-grade speech analytics company, to add voice-based cognitive assessment to its platform. The deal includes Aural's Speech Vitals technology, which has been used to detect conditions like dementia and ALS. The acquisition expands Linus Health's operations into life sciences and aims to improve early detection of brain disorders.YahooLinus Health Acquires Aural AnalyticsLinus Health acquired Aural Analytics, a clinical-grade speech analytics company, to expand its cognitive assessment platform. The deal includes Aural's Speech Vitals technology, which has been used to detect conditions like dementia and ALS. The acquisition aims to integrate speech analysis into Linus's multimodal assessments for earlier brain health detection.PR NewswireLinus Health Acquires Aural AnalyticsLinus Health acquired Aural Analytics, a clinical-grade speech analytics company, to add voice-based cognitive assessment to its platform. The deal includes Aural's Speech Vitals software, which has been used to detect conditions like dementia and ALS. The acquisition expands Linus Health's operations into life sciences and aims to improve early detection of brain disorders.AI Business InformsNew Trend in Medical AI: Diagnosing Diseases From SpeechThe FDA's AI/ML-enabled medical device approvals rose 52% to 521, with most in radiology. A new trend uses speech-based vocal biomarkers for diagnosis, with Aural Analytics registered a device and Winterlight Labs running trials. Challenges include unclear FDA pathways, false positives, and data privacy concerns.